X-Zell Inc.
- Home
- Companies
- X-Zell Inc.
- Articles
- Case Study A - Next-Gen Cytology
Case Study A - Next-Gen Cytology
Jan. 11, 2023
Courtesy ofX-Zell Inc.
X-ZELL is collaborating with one of Germany’s leading cytopathology centres to introduce Cryoimmunostaining™ into routine cytology as a tool to efficiently analyse lung fluids such as bronchoalveolar lavage and pleural effusion and enable near-instant diagnoses through digital on-screen analysis.
According to the German Association of Pathology (BdP), X-ZELL Cryoimmunostaining™ is eligible for reimbursement under the EBM and GOÄ systems.
- 93 per cent time reduction from sample to diagnosis by eliminating cell block preparation
- 700% per cent data increase per sample through multi-channel immunostaining
- More capacity on existing IHC equipment due to reduced restaining
Most popular related searches